| Old Articles: <Older 1251-1255 |
 |
Fast Company April 2013 Max Chafkin |
True To Its Roots: Why Kickstarter Won't Sell The crowdfunding site has made some people rich and sent others away angry -- forfeiting millions of dollars in the process. For the first time, its founders explain why they refuse to act like other startups.  |
Fast Company April 2013 Farhad Manjoo |
When It Comes To Tech Investing, VCS Are Venturing Forth Cautiously Growing uncertainty in tech is creating chaos for startups, consumers, and investors.  |
Chemistry World February 1, 2013 Andrew Turley |
Zoetis IPO launches at $2.2bn The separation of Pfizer from its animal health business, Zoetis, has begun. Pfizer has priced its initial public offering of 86 million shares at $26 per share, for a total of $2.2 billion  |
CIO January 30, 2013 |
CIOs See Risks and Rewards in Startup Mania Investing in cutting-edge technologies could lead to big rewards, but it also brings incredible risk for CIOs, says Michael Friedenberg  |
Chemistry World October 31, 2012 Derek Lowe |
High finance meets big pharma? MIT professor and hedge-fund manager Andrew Lo has a plan to gather together as many plausible early-stage oncology projects as possible, and raise money by 'securitizing' their future revenues and issuing bonds from this portfolio.  |
| <Older 1251-1255 Return to current articles. |